Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)
0.3607
-0.4090
(-53.14%)
Official Closing Price
Updated: 8:00 PM EST, Mar 6, 2026
Add to My Watchlist
Press Releases about Calidi Biotherapeutics, Inc. Common Stock
Cancer Stress Protein Enables Tumors to Evade the Immune System
February 20, 2026
Existing Cancer Drug Shows Potential in Reactivating Immunotherapy
February 17, 2026
Early Symptoms of Lung Cancer You Could Be Ignoring
February 12, 2026
Scientists Discover Why Immunotherapy Frequently Fails
February 04, 2026
Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy
October 22, 2025
Novel Therapy Helps Tumor Cells Welcome Cancer Treatment
January 28, 2026
New Approach Could Increase Response Rates for Cancer Immunotherapy
December 23, 2025
Novel Biomarker Could Predict Resistance to Immunotherapy, Study Finds
December 17, 2025
Study Highlights Increasing Cases of Breast Cancer in Younger Women
December 12, 2025
Study Proposes Overhaul of US Lung Cancer Screening Guidelines
December 08, 2025
What Patients Need to Know About Exercising During Cancer Treatment
November 21, 2025
Rarest Natural Element Promises to Revolutionize How Cancer is Treated
November 13, 2025
Lung Cancer Screening is Still Woefully Low in the US, Report Shows
November 04, 2025
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
October 24, 2025
Researchers Urge Canadians to Donate Toenails, for Science
October 16, 2025
Researchers Discover Why Cancer Immunotherapy Could Be Failing
October 08, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.